BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Cinven Ltd. Snaps Up Amdipharm for $590 Million


10/16/2012 8:09:16 AM

Private equity group Cinven CINV.UL is buying family-owned niche pharmaceuticals business Amdipharm for 367 million pounds ($590 million), it said on Monday, as part of a plan to create a much larger producer of generic drugs worth as much as 2 billion pounds ($3 billion). The aim is to merge Amdipharm with Mercury Pharma, which Cinven bought from rival private equity house HgCapital in August for 465 million pounds, and to expand the combined business. "We absolutely want to buy more products from the larger pharmaceutical companies that are looking to tidy up their portfolios," said Cinven deal partner Supraj Rajagopalan in an telephone interview with Reuters. "I certainly could see an end business which is more than twice the size of what it is today," Rajagopalan added. Amdipharm was created in 2002, with a shift in the focus of big drug companies away from smaller and older products giving it an opportunity to snap up "legacy products" - typically off-patent generic drugs in niche disease areas.


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->